Medicamen Biotech informs about disclosure

04 Jun 2018 Evaluate

Medicamen Biotech has informed that the Company has received Disclosures in terms of regulation 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Promoters for release of 16,61,200 shares pledged with Union Bank of India.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

352.70 -13.40 (-3.66%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×